Back to Journals » Drug Design, Development and Therapy » Volume 13

Clinical Trial Report

Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system

         
Total article views   Abstract views HTML views PDF downloads Totals
4,305 Dovepress* 3,491 380+ 916 3,871
PubMed Central* 0 434 158 434
Totals 3,491 814 1,074 4,305
*Since 12 March 2019
+Since July 2016

View citations on PubMed Central and Google Scholar